Richard has held drug discovery positions at Novo Nordisk and, currently, a regional medical affairs position at MSD. Richard also holds an honourary position at University College, London (UCL). He was responsible for the initial proposal/discovery of the DPP4 inhibitor approach. The concept was originally conceived in 1993 and eventually published in 1995. At UCL, he is a member of a team involved with basic research with a special emphasis on cardioprotection. He has co-authored approximately 80 original peer-reviewed full publications (H-index currently being 34), together with 10 published patent applications and grants.